Form D · Biotechnology
NEUROLUTIONS INC
Van Nuys, CA · CIK 0001450737
Offering snapshot reported Mar 17, 2025 · SEC filing
- Reported sold
- $26.5M Offering amount: $42.8M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 17, 2025 | Initial | $26,549,999 | No comparison | 9 | SEC filing |
| Nov 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-541054
Source: Form D, filed Mar 17, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Fred Khosravi | Director |
| Eric Leuthardt | Director |
| Leo Petrossian | Director, Executive |
| Kevin Reilly | Director |
| Amarpreet Sawhney | Director |
| Yuanwei Tai | Director |
| Stavros Vizirgianakis | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7033 Hayvenhurst Ave
Van Nuys, CA, 91406
Van Nuys, CA, 91406